Reply to: Delirium and sleep quality in the intensive care unit: the role of melatonin
Rodrigo Bernardo Serafim, Pedro Henrique Rigotti Soares

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsIntensive Care Unit Cognitive Disorders · Anesthesia and Neurotoxicity Research · Family and Patient Care in Intensive Care Units
To the Editor,
We read with interest the correspondence by Finsterer et al. and would like to offer a few comments.^(1)^ Sleep disruption and delirium in the intensive care unit (ICU) result from a complex interplay of individual, environmental, and pharmacological factors. The influence of ICU type, genetic predisposition, psychiatric history, and internal stressors is indeed relevant and contributes to this multifactorial syndrome.^(2,3)^
While acknowledging these numerous contributors, it is important to recognize that many are not modifiable. In addition, several interventions commonly associated with delirium, such as sedation, mechanical ventilation, and invasive monitoring, are often indispensable for the appropriate management of critical illness. In daily ICU practice, clinical focus frequently shifts toward symptom control and the implementation of feasible, low-risk strategies, particularly when high-quality evidence is limited. Within this context, sleep hygiene optimization and melatonin use may serve as adjunctive tools rather than substitutes for comprehensive delirium prevention protocols.^(4)^
Nonpharmacological interventions remain the cornerstone of delirium prevention and management in the ICU. Addressing modifiable risk factors is essential, including medication reconciliation, immobility, sleep disruption, and sensory deprivation. Furthermore, proper triage and the allocation of truly high-risk patients to intensive care while avoiding inappropriate ICU admissions are also key strategies for delirium prevention.^(5,6)^
Melatonin is not recommended as a direct treatment for delirium, but it may aid in restoring circadian rhythms and improving sleep quality, which could indirectly reduce the risk of delirium.^(7,8)^ Given the limited number of pharmacologic options with proven efficacy in the ICU setting, melatonin remains a biologically plausible and safe candidate that warrants further investigation.^(3,7)^
Finally, we agree that delirium requires prompt recognition and, in selected cases, psychiatric consultation. Nonetheless, early and multimodal prevention must be a shared responsibility of the multidisciplinary team. Intensivists should be able to promptly identify, treat, and address underlying causes in critically ill patients. Therefore, systematic screening using validated tools such as Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) or Intensive Care Delirium Screening Checklist (ICDSC), ideally integrated into daily clinical assessments, is essential for timely diagnosis and management.^(3)^
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Finsterer J Mehri S To: Delirium and sleep quality in the intensive care unit: the role of melatonin Crit Care Sci 202537 e 202502804053169210.62675/2965-2774.20250280 · doi ↗ · pubmed ↗
- 2Ely EW Shintani A Truman B Speroff T Gordon SM Harrell FE Jr Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit JAMA 200429114175317621508270310.1001/jama.291.14.1753 · doi ↗ · pubmed ↗
- 3Devlin JW Skrobik Y Gélinas C Needham DM Slooter AJ Pandharipande PP Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU Crit Care Med 2018469 e 825e 8733011337910.1097/CCM.0000000000003299 · doi ↗ · pubmed ↗
- 4Soares PH Serafim RB Delirium and sleep quality in the intensive care unit: the role of melatonin Crit Care Sci 202436 e 20240083 en 10.62675/2965-2774.20240083-en PMC 1109806838775566 · doi ↗ · pubmed ↗
- 5Slooter AJ Otte WM Devlin JW Arora RC Bleck TP Claassen J Updated nomenclature of delirium and acute encephalopathy: statement of ten societies Intensive Care Med 2020465102010223205588710.1007/s 00134-019-05907-4PMC 7210231 · doi ↗ · pubmed ↗
- 6Halpern NA Pastores SM Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs Crit Care Med 201038165711973025710.1097/CCM.0b 013e 3181 b 090d 0 · doi ↗ · pubmed ↗
- 7Bourne RS Mills GH Minelli C Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial Crit Care 2008122 R 52R 521842300910.1186/cc 6871 PMC 2447606 · doi ↗ · pubmed ↗
- 8Marra A Mc Grane TJ Henson CP Pandharipande PP Melatonin in Critical Care Crit Care Clin 20193523293403078461310.1016/j.ccc.2018.11.008 · doi ↗ · pubmed ↗
